MacDougall Biomedical Communications, Inc.

MacDougall Biomedical Communications Inc.(MBI) was founded in 2002 to fulfill the communications needs of small to medium sized private and public biotechnology companies. The staff at MBI has tremendous industry experience, having provided investor, corporate and scientific outreach programs to over 100 clients in the life sciences industry. MBI works with companies ranging from early stage start-ups that have no internal communications capabilities to billion dollar market cap public companies that have full-time communications staff. MBI has managed major event and visibility projects for the Biotechnology Industry Organization and other regional biotechnology organizations. The team at MBI prides itself in being innovative and creative with a results-oriented approach. MBI has also built a broad network of the best corporate communications specialists worldwide to implement larger programs as needed.
"The most important measurements of success in the biotechnology industry are management's ability to build third-party endorsement of its programs and to proactively manage the expectations of its constituencies…investors, partners, clinical and scientific community, patients, shareholders, media, employees, etc."
- Douglas MacDougall, President, MBI

Contact Details: 190 North Main Street3rd Floor Natick Massachusetts 01760 United States of America Tel: (508) 647-0209 Fax: (508) 647-1501 Email: WWW: www.macbiocom.com/

Loading...

Press Releases on MacDougall Biomedical Communications, Inc.:
Surface Logix Raises $20 Million in Financing and Starts Phase 2b Clinical Trial of SLx-4090 in Dyslipidemia and Diabetes	9th March, 2009	Surface Logix Inc.	Contact: Warwick Tong, MD Surface Logix Inc. Sr. Vice President, Corporate Development 617.746.8505 Media: Sarah Cavanaugh MacDougall Biomedical Communications Inc.
Surface Logix Appoints Keith Dionne as President and Chief Executive Officer	14th October, 2008	Surface Logix Inc.	BOSTON, Oct. 14 /PRNewswire/ -- Surface Logix, a privately held biopharmaceutical company focused on using biophysical chemistry to create and develop novel small molecule drugs, is pleased to

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 368 times since April 2007, the link to the organisation's website has been followed 57 times

Recent Search Terms used to find this page: macdougall biomedical communications inc. | macdougall biomedical communications inc. | doug mcdougall biotech | mcdougall communications | macdougall biomedical communcations | Doug McDougall communications | .

Search for more companies in Natick

Search for more companies in Massachusetts

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for MacDougall Biomedical Communications, Inc.